Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 Jan 25 | RNAC Cartesian Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 2,600 | 0.00 | 24,366 |
2 Jan 25 | RNAC Cartesian Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 16.93 | 7,800 | 132.05 k | 7,800 |
12 Aug 24 | RNAC Cartesian Therapeutics | Common Stock | Buy | Acquire P | No | No | 12.7 | 7,500 | 95.25 k | 21,766 |
2 Jan 24 | RNAC Cartesian Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 178,000 | 0.00 | 428,013 |
2 Jan 24 | RNAC Cartesian Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.6552 | 228,000 | 149.39 k | 228,000 |
13 Nov 23 | RNAC Cartesian Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 0.93 | 87,500 | 81.38 k | 0 |
13 Nov 23 | RNAC Cartesian Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 3.31 | 40,000 | 132.40 k | 0 |
13 Nov 23 | RNAC Cartesian Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 4.01 | 40,000 | 160.40 k | 0 |
13 Nov 23 | RNAC Cartesian Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 3 | 20,000 | 60.00 k | 0 |
13 Nov 23 | RNAC Cartesian Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 12.75 | 10,000 | 127.50 k | 0 |